Upload
lexie-woolf
View
220
Download
3
Embed Size (px)
Citation preview
DPT 8.0
The Biologic Incident
Management of Biological Casualties
DPT 8.0
Hospital Management of Biological Casualties
DPT 8.0
Biological Warfare AgentsTerminal Objective
• Be able to describe the various types of biological warfare agents and recognize the signs and symptoms of exposure.
• Be able to describe how to properly manage and treat infectious victims
• Know which agents are a risk for secondary transmission and how to protect against this spread using personal protective equipment (PPE) and isolation measures.
DPT 8.0
Biological Warfare (BW) Agents - History
• Oldest of the NBC triad of agents
• Used for > 2,000 years
– Sieges of middle ages
– Smallpox blankets given to Native Americans
– Germany in World War I
– Japan in World War II
DPT 8.0
Aerosol / Infectivity Relationship
18-20
15-18
7-12
4-6(bronchioles)
1-5 (alveoli)
Infection SeverityParticle Size
(Micron, Mass Median Diameter)
The ideal aerosol contains a homogeneous population
of 2 or 3 micron particulates that contain one or more
viable organisms
Maximum human respiratory infection is
a particle that falls within the 1 to 5 micron
size
Less Severe
More Severe
DPT 8.0
BW - Epidemiologic Clues
• Large epidemic with high illness and death rate
• HIV(+) individuals may have first susceptibility
• Respiratory symptoms predominate
• Infection non-endemic for region
• Multiple, simultaneous outbreaks
• Multi-drug-resistant pathogens
• Sick or dead animals
• Delivery vehicle or intelligence information
DPT 8.0
BW - Epidemiological Information
• Travel history
• Infectious contacts
• Employment history
• Activities over the preceding 3 to 5 days
DPT 8.0
Biological Agents - Types and Characteristics
• Bacteria
• Viruses
• Toxins
DPT 8.0
Bacteria as Biological Agents
• Bacteria– Single celled microorganism
– Invade tissue; cause inflammatory reaction or produce toxins
– May form spores
• Anthrax
• Plague
• Tularemia
• Q Fever
DPT 8.0
Anthrax - Microbiology
• Bacillus anthracis - gram +, spore-forming bacillus
• Endemic infection in animals
• Humans develop infection naturally from handling contaminated fluids or hides (“Woolsorters Disease”)
DPT 8.0
Anthrax - Pathogenesis
• Inoculation, ingestion, or inhalation of spores which may travel to the regional lymph nodes
• Vegetative bacteria produce edema factor and lethal factor (toxins)
• Inhalation route has highest mortality and is most likely route to be used by terrorists
• Inhaled anthrax causes a mediastinitis rather than a pneumonia
• Untreated skin infection - 21% mortality if septicemia develops (treated 1%)
DPT 8.0
Cutaneous Anthrax
DPT 8.0
Gastrointestinal Anthrax
DPT 8.0
Inhalational Anthrax
• 2 to 6-day incubation period followed by fever, myalgias, cough, and fatigue
• Initial improvement followed by abrupt onset of respiratory distress, shock, and death in 24 to 36 hours
• Physical findings are nonspecific, pneumonia is rare
• Chest x-ray - may show widened mediastinum with or without a bloody pleural effusion
• 50 % of cases have associated hemorrhagic meningitis
DPT 8.0
Prevention of Secondary Anthrax Transmission
• No documented cases of person-to-person transmission of inhalational anthrax has ever occurred
• Cutaneous transmissions are possible
• Universal precautions required
DPT 8.0
Anthrax - Soviet Incident
An accident at a Soviet military compound in Sverdlovsk (microbiology facility) in 1979 resulted in an estimated 66 deaths downwind.
Biological Warfare research,
production and storage facility
Biological Warfare research,
production and storage facility
Path of airborne Anthrax
Path of airborne Anthrax
MOSCOW
Sverdlovsk
DPT 8.0
Inhalational Anthrax - Sverdlovsk
DPT 8.0
Inhalational Anthrax Post Mortem - Sverdlovsk
DPT 8.0
BW Anthrax - Diagnosis
• Clinical picture of sudden onset of respiratory distress with mediastinal widening on x-ray
• A small number of patients may present with GI or cutaneous anthrax
• Gram stain of blood and blood cultures - but these may be late findings in the course of the illness
• ELISA and immunohistology testing may confirm diagnosis but samples must go to reference laboratory
DPT 8.0
Anthrax - Treatment
Acute Treatment
• Usually futile in severe mediastinitis patients who inhaled or ingested spores
• Ciprofloxacin - 400 mg IV q 8 to 12 hr
• Doxycycline - 100 mg IV q 12 hr X 4 wks
• Vaccination begins at the start of drug therapy
Post-exposure
• Oral prophylaxis
– Ciprofloxacin (500 mg po q 12 h) X 4 wks until 3 doses of vaccine
– Doxycycline (100 mg po q 12 h) X 4 wks until 3 doses of vaccine
• FDA licensed vaccine
DPT 8.0
Anthrax - Pediatric Treatment
Prophylaxis
• Penicillin
• Doxycycline
IV Therapy
• Penicillin
• Doxycycline
DPT 8.0
Anthrax Disease Complex Summary
GI
Papule vesicleedema + eschar
ResolveToxic shock
andDeath
HemorrhagicMeningitis
Cutaneous
Inhalational
Tracheobronchial Lymphadenitis
Mediastinitis, cyanosis,stridor, pulmonary
edema
1 - 6 days
ABRUPT ONSET
50%
20%
24 - 36 hours
DPT 8.0
Plague - Microbiology
• Yersinia pestis - gram(-), non-motile, non-spore forming bacillus
• Fleas living on infected rodents spread infection to humans
• Recovery offers temporary immunity
DPT 8.0
Plague - Pathogenesis
• Produces disease by being consumed by macrophages and transported to regional lymph nodes, causing regional adenitis
• Bacteremia - spread to other organs (lungs, spleen, liver, and brain)
DPT 8.0
Plague Transmission
PNEUMONIC
BUBONIC
and
SEPTICEMIC
SECONDARY PNEUMONIC and
OROPHARYNGEAL
Fleas (active or dormant)
Rodent
Aerosol
Surface contact
DPT 8.0
Pneumonic PlaguePrevention of Secondary Infection
• Secondary transmission is possible and likely
• Standard, contact, and aerosol precautions for at least 48 hrs until sputum cultures are negative or pneumonic plague is excluded
DPT 8.0
Plague Endemic Counties
Counties with Plague-Positive Samples
1970 - 1994
DPT 8.0
Inhalational (Pneumonic) Plague Signs and Symptoms
• 2 to 3 day incubation period followed by high fever, myalgias, chills, HA, and cough with bloody sputum
• In contrast to anthrax, pneumonia and sepsis develop acutely and may be fulminant with patients developing dyspnea, stridor, cyanosis, and circulatory collapse
• Patchy infiltrates or consolidation seen on chest x-ray
DPT 8.0
Bubonic PlagueSigns and Symptoms
• Erythema, fever, rigors
• Bubo formation in regional lymph nodes
• Bubo aspiration and gram stain is diagnostic– Differentiate from• Tularemia• Cat-scratch fever
• Staph-strep lymphadenitis
DPT 8.0
Acral Gangrene
Acral gangrene may be a late complication of pneumonic or septicemic plague, and may occur in the finger, toes, earlobes, nose, and penis.
DPT 8.0
Plague - Acral Gangrene
DPT 8.0
Plague - Diagnosis
• Gram stain and culture of lymph node aspirates, sputum, or CSF samples
• Bipolar staining “Safety Pin” may be present
• Immunoassays are also available
DPT 8.0
Plague - Treatment
• Care is otherwise supportive• Vaccine effective only for bubonic plague • Prophylaxis - tetracycline or doxycycline• Antibiotics must be started within 24 hours of symptoms to
impact survival• Streptomycin (30 mg/kg/day IM divided BID for 10 days)• Doxycycline (100 mg IV BID for 10 days)• Chloramphenicol for plague meningitis
Respiratory isolation mandatory for at least the first 48 hours of treatment
DPT 8.0
Plague - Pediatric Treatment
Prophylaxis
• Doxycycline
• Trimethoprim/Sulfamethoxazole
IV Therapy
• Streptomycin (over 1 year of age)
• Gentamicin
• Chloramphenicol
DPT 8.0
Plague Disease Complex
Inhalational
SystemicToxicity
Respiratory failure & circulatory collapse
Liverenzymes
6% latemeningitis
Fulminant Pneumonia
Fever, URI syndrome
Sudden onset
Leukemoidreaction
Gram - verods in sputum
Fever/rigors Erythema
Tender bubo1 - 10 cm
APTTecchymosis
DIC
Stridor, cyanosis,productive cough,bilateral infiltrates
Pharyngitis2 -3 days 2 - 10 days
24 hrs
9%
DPT 8.0
Viruses as Biological Agents
• Smallpox
• Viral Hemorrhagic
Fevers (VHF)
• Venezuelan Equine
Encephalitis (VEE)
DPT 8.0
Viruses - General Characteristics
• RNA or DNA within a protein coat
• Require a host to function and survive
• Many viruses attack a specific type of cell causing disease or cancer
DPT 8.0
Viruses - General Characteristics
• May cause disease through direct cytopathic effect, immune complex deposition and other effects
• May result in end-organ system failure, vascular damage
• Few antiviral medications available
• Vaccination is the most effective means of preventing infection
DPT 8.0
Smallpox - Microbiology
• Variola (Var-ï-óla) virus, an Orthopox virus, both minor and major forms of smallpox exist
• Structure is a large DNA virus
• Declared eradicated in 1980 and the U.S. stopped its civilian vaccination in 1981, U.S. military stopped in 1985
DPT 8.0
Smallpox - Pathogenesis
DPT 8.0
Smallpox - Case Study
• In 1963, en route by air from Australia to Sweden, a seaman stops in Djakarta, Singapore, Rangoon, Calcutta, Karachi, Teheran, Damascus, and Zurich
• Fifteen days later he develops a fever and rash
• Diagnosed with smallpox; 19 cases identified
• More than 300,000 vaccinated worldwide
DPT 8.0
Smallpox - Diagnosis & Treatment
DIAGNOSIS
• Clinical presentation
• Demonstrate virus from vesicular sampling via electron microscopy
• Confirmation by tissue culture
TREATMENT
• Supportive
• Vaccine still available from CDC
• Immune globulin may also be available from CDC
DPT 8.0
Smallpox - Prevention of Secondary Infection
• Contagious
• All contacts are quarantined for at least 17 days
• Infectious until all scabs are healed over
DPT 8.0
Monkeypox Virus
DPT 8.0
Smallpox / Monkeypox - Clinical Course Summary
Inhalational
Replication in regional node of airways12 day incubation
ViremiaAcute malaise, fever,rigors, headache
Exanthema onface, arms, hands
Macules papules pustular vesicles
Scabs separate+ pt non-infective
Flat Smallpox
HemorrhagicSmallpoxrapid death beforetypical lesions
8 - 10 days
2 - 3 days
variants
+ mental status changes
DPT 8.0
Viral Hemorrhagic Fevers (VHF) - Microbiology
• RNA viruses causing high fevers and generalized vascular damage
• Human infections by insect bites or by contact with blood and body fluids
DPT 8.0
VHF Pathogenesis
• Fever, myalgias, prostration
• Cases evolve into shock and generalized mucous membrane hemorrhage
• Conjunctival injection, petechial hemorrhage, and hypotension
• Abnormal renal and LFT - poor prognosis
• Mortality varies; 50 - 80% Ebola Zaire
• Disease severity and survival depends on various host factors; target organ is the vascular bed.
DPT 8.0
VHF Treatment
• Hemodynamic resuscitation and monitoring– Invasive Swan Gantz catheter as feasible
• Careful fluid management– use of colloid
• Vasopressors and cardiotonic drugs
• Cautious sedation and analgesia
• No anti-platelet drugs or IM injections
• Coagulation studies and replacement of clotting factors / platelet transfusions
DPT 8.0
Prevention of Secondary VHF Transmission
• No vaccine is available at this time
• Single room w/ adjoining anteroom as only entrance
– handwashing facility with decontamination solution
• Negative air pressure if possible
• Strict barrier precautions
– gloves, gown, mask. shoe covers, protective eyeware/faceshield
– consider HEPA respirator for prominent hemorrhage, vomiting, diarrhea, cough
DPT 8.0
Prevention of Secondary VHF Transmission
• Chemical toilet
• All body fluids disinfected
• Disposable equipment/sharps into rigid containers and autoclaved/incinerated
• Double-bag refuse-outside bag disinfected
• Electronic/mechanical equipment can be paraformaldehyde disinfected
DPT 8.0
Prevention of Secondary VHF Transmission
• Wash / irrigate wound site immediately
• Mucous membranes (eye, mouth, nose)
– Continuous irrigation with rapidly flowing water or sterile saline for >15 minutes
• Skin
– Scrub for >15 minutes while copiously soaking the wound with detergent solution
– Germicidal solution
(Dilute 1 part laundry bleach with 9 parts tap water)
DPT 8.0
The VHF RNA Viruses
Acute onsetfebrile illness
High fever, myalgia,GI disturbances
Severe systemic illnesscoagulation abnormalities
Rapid progression into shock and death
Renalfailure
Pulmonary Syndrome
Majororgan
necrosis
Four Corners Agent
Ebola
Marburg
Hantaan
Oropharangeal lesions
Severe bleedingecchymosis
Jaundice Syndrome
Lassa
Machupo
Congo fever
Yellow feverDengue (2x)Rift Valley
7 days
DPT 8.0
• April 5, 1995 - Zaire laboratory worker - fever and bloody diarrhea
• May 17 - 93 cases - 92% fatality - most cases were in health care providers
• June 25 - 296 cases
Ebola Case Study
When institutional barrier precautions were implemented by WHO/CDC - the infection rate
among health care workers dramatically decreased.
DPT 8.0
Toxins as Biological Agents
• Botulinum
• Ricin
• Staphylococcal Enterotoxin B (SEB)
DPT 8.0
Toxins General Characteristics
• Naturally produced poisons
• More toxic per weight than manmade chemical agents
• Non-volatile
• Minimal absorption in intact skin
• Not prone to person-to-person transmission
DPT 8.0
Botulinum Toxin - Characteristics
• Neurotoxin produced by Clostridium botulinum - Botulism
• Most lethal compound per weight (15,000 times more toxic than the nerve agent VX)
• Different toxicity if inhaled or ingested
HcHc
HNHN
light chainlight chainneutralizing epitopesneutralizing epitopes
Bot A ToxinBot A Toxin
DPT 8.0
Botulism - Pathogenesis
• Blocks the release of ACh at 3 places in the presynaptic terminal of the neuromuscular junction and autonomic nervous system
• Bulbar palsies and skeletal muscle weakness MUSCLE
NERVE
DPT 8.0
Botulism - Signs & Symptoms
• Descending paralysis
• Bulbar palsies – blurred vision– mydriasis– diplopia– ptosis– photophobia– dysphagia– dysarthria
“Floppy” babyflaccid paralysis
DPT 8.0
Botulism - Diagnosis and Treatment
• Clinical diagnosis - bulbar palsy with descending paralysis
• Mouse neutralization assay can confirm diagnosis
• Treatment is supportive
– Long-term mechanical ventilation
• Antitoxins are available; must be administered early
• CDC vaccine protective for A and B toxins
DPT 8.0
Ricin - Characteristics
• Toxic by multiple routes of exposure
• Can be dispersed as an aerosol
• Effective orally, by injection, or inhalation
DPT 8.0
Ricin - Pathogenesis
DPT 8.0
Ricin - Signs & Symptoms
• Fever, chest tightness, cough, SOB, nausea, and joint pain 4 to 8 hours after inhalation
• Airway necrosis and edema leads to death in 36 to 72 hours
• Ingestion causes N,V, severe diarrhea, GI hemorrhage, and necrosis of the liver, spleen, and kidneys - shock and death within 3 days
• Injection causes marked necrosis of muscles and lymph nodes with multiple organ failure leading to death
DPT 8.0
Ricin - Diagnosis & Treatment
DIAGNOSIS
• Difficult
• Routine labs are nonspecific
• ELISA of blood
• Immunohistochemical tests may confirm
TREATMENT
• Supportive - oxygenation and hydration
• No antitoxin or vaccine available
DPT 8.0
Teaching Points
• BW EXPOSURE: WET OR DRY AGENT AEROSOLS• BACTERIAL AGENTS
– LETHAL: Anthrax, Tularemia, Plague– NON-LETHAL: Q Fever
• VIRAL AGENTS
– LETHAL: Smallpox / Monkeypox, Viral Hemorrhagic Fevers
– NON-LETHAL: Venezuelan Equine Encephalitis
• TOXINS– LETHAL: Ricin, Botulinum Toxin A– NON-LETHAL: Staphyloccal Enterotoxin B
• SECONDARY INFECTION IS POSSIBLE WITH– Plague, Smallpox/Monkeypox, and VHF
DPT 8.0
Biological Agents
Case Study
Emergency departments always seem busier during a full moon despite evidence to the contrary. Tonight was no exception. Over a 6-hour period, it seemed that almost half of the patients presented with similar complaints of high fever, cough, shortness of breath, and generalized ill feeling. Five young, previously healthy individuals required intubation and mechanical ventilation for severe respiratory distress. Strangely, most of the patients knew each other from work and none of their family members were suffering similar symptoms. At 11 p.m., the only other community hospital in the area went on diversion because all of their intensive care unit (ICU) beds were full and their need for mechanical ventilators was at a critical level. The public health officer on call was not aware of any recent infectious outbreak.
DPT 8.0
Biological Agents
• What might the causative agent be?
• How could you identify common factors which might relate
the patients to each other?
• How long ago might the attack have occurred?
• If you are suspicious that patient illnesses could be the
result of a biological attack, whom should you notify?
• What precautions should you and other healthcare
providers take?